Who are AELIX Therapeutics's investors?

AELIX Therapeutics's investors include Criteria Bio Ventures, Ysios Capital.

Where is AELIX Therapeutics headquartered?

AELIX Therapeutics is headquartered in Barcelona, ES.

AELIX Therapeutics

Barcelona, ES · 2 known investors

AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies. It operates in the biotech and vaccine development sector.

BiotechHealthtech

Investors · 2

Criteria Bio VenturesBarcelona

Ysios CapitalBarcelona · $5.4M – $21.6M

In the news

Gilead acquires investigational assets for the HIV vaccine from AELIX Therapeutics - Parc Científic de Barcelonapcb.ub.edu · Nov 2024

AELIX Therapeutics and Gilead Sciences to jointly trial new HIV therapyclinicaltrialsarena.com · Oct 2018

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure - BioSpacebiospace.com · Oct 2018

Frequently asked questions

What does AELIX Therapeutics do?: AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies. It operates in the biotech and vaccine development sector.
Who are AELIX Therapeutics's investors?: AELIX Therapeutics's investors include Criteria Bio Ventures, Ysios Capital.
Where is AELIX Therapeutics headquartered?: AELIX Therapeutics is headquartered in Barcelona, ES.